Advanced Elementary...
Services: Diversified Services
Furiex Pharmaceuticals Inc. (FURX: NASDAQ)
$36.93 1.00 | 2.78%
06/18/13 - 04:00 PM ET
97.57K / 67.60K
Vol / Avg. Vol:35.98 / 35.93
Open / Prev. Close:35.71 - 36.99
Today's Range:17.50 - 42.30
52 Wk Range:91.74%
Performance YTD:TheStreet Rating:
Portfolios with FURX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- User0730
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
Latest FURX Headlines from TheStreet
- Ratings Moves: BYD, DLB, UPS
05.30.13 | 12:05 pm - Furiex Pharmaceuticals Inc. Stock Downgraded (FURX) 05.30.13 | 10:05 am
- 4 Stocks Spiking on Unusual Volume 02.14.13 | 07:02 am
- These 10 ¿¿Buyâ¿ Rated Stocks Have Significant Insider Buying Activity 02.06.13 | 02:02 pm
- Stocks Mixed as Investors Take Breather 01.28.13 | 02:01 pm
- Stock Futures Rise After Caterpillar, Durable Goods Reports 01.28.13 | 09:01 am
- Furiex Pharmaceuticals Inc. Stock Upgraded (FURX) 11.27.12 | 04:11 am
- 7 Stocks Rising on Unusual Volume 07.30.12 | 02:07 pm
- Insiders Trading END, HUTC, FURX, SNI 06.18.12 | 10:06 am
- Insiders Trading HPQ, LNKD, FURX, CPRT 06.05.12 | 10:06 am
Press Releases for FURX
- Furiex Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 03.06.13 | 04:03 pm
- Furiex Pharmaceuticals To Present At Cowen & Company 33rd Annual Healthcare Conference - Business Wire 02.26.13 | 09:02 am
- Furiex Receives Qualified Infectious Disease Product And Fast Track Designations From The U.S. Food And Drug Administration For Avarofloxacin (JNJ-Q2) - Business Wire 02.25.13 | 04:02 pm
- Furiex Pharmaceuticals Announces Fourth Quarter And Full Year 2012 Earnings Release And Conference Call - Business Wire 01.29.13 | 04:01 pm
- Furiex Confirms Takeda’s Receipt Of FDA Approval Of NESINA (alogliptin) And Fixed-Dose Combinations OSENI (alogliptin And Pioglitazone) And KAZANO (alogliptin And Metformin HCl) For The Treatment Of Type 2 Diabetes - Business Wire 01.25.13 | 07:01 pm
- Furiex Reports Third Quarter 2012 Financial Results - Business Wire 11.01.12 | 04:11 pm
- Furiex Pharmaceuticals Announces Third Quarter 2012 Earnings Release And Conference Call - Business Wire 10.01.12 | 04:10 pm
- Furiex Reports Second Quarter 2012 Financial Results - Business Wire 08.02.12 | 04:08 pm
- Furiex Pharmaceuticals Amends Current Loan And Security Agreement, Adding An Additional $30.0 Million - Business Wire 08.02.12 | 04:08 pm
- Furiex Pharmaceuticals Announces Closing Of Priligy® Asset Transfer And License Agreements - Business Wire 07.30.12 | 04:07 pm
Partner Headlines for FURX
- 5 Pharmaceutical Companies With Insider Buying During August 14-16 - Seeking Alpha 08.19.12 | 05:08 am
- Insider Trades: Opportunity Or Sham? - Seeking Alpha 08.19.12 | 05:08 am
- Furiex Confirms Takeda's Resubmissions of Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone NDAs to FDA - Benzinga 07.27.12 | 04:07 pm
- Healthcare Business Rewind: Furiex' GOOD NEWS, Pfizer TERMINATES Licenses - Wall St. Cheat Sheet 07.27.12 | 06:07 am
- 3 Outperforming Small Caps Bought Up By Insiders And Hedge Funds - Seeking Alpha 04.13.12 | 07:04 pm
- Furiex Pharmaceutical's Coming Events Could Boost Stock Price - Seeking Alpha 03.26.12 | 09:03 am
- Insider Buys And Sells: Sohu, Tesla - Seeking Alpha 03.19.12 | 09:03 am
- Heavy Activity For Furiex Pharmaceuticals In 2012 - Seeking Alpha 01.23.12 | 08:01 am
- Furiex Confirms Takeda Launches LIOVEL LD and LIOVEL HD, a Fixed Dose Combination of NESINA and ACTOS, for Type 2 Diabetes in Japan - Benzinga 09.20.11 | 01:09 pm
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.27.11 | 09:07 am
